Project Description

Strategy Inc. performed a TechSelect Analysis on eight of our developing technologies at LA BioMed, the Los Angeles Biomedical Research Institute at Harbor-UCLA. Medical Center. This in depth business analysis provided a framework for successful commercialization for a wide range of technologies at very different stages of development and is incredibly helpful.” David Meyer PhD, President and CEO, LA BioMed

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) is one of the country’s leading nonprofit biomedical research institutes with 150 researchers advancing lifescience innovation.